NCT00368966 - Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. | Biotech Hunter

Enrollment

619

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Vaccines, Pneumococcal

Interventions

BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

BIOLOGICAL

7-valent Pneumococcal Conjugate Vaccine

Trial Locations (41)

15006

A Coruña

15270

A Coruña

15405

Ferrol

15706

Santiago de Compostela

27880

Burela de Cabo

28021

Madrid

28041

Madrid

28900

Getafe

28902

Getafe

28922

Alcorcón

28937

Móstoles

28943

Fuenlabrada

28980

Parla

29015

Málaga

29200

Antequera

31008

Pamplona

32005

Ourense

36204

Vigo

41013

Seville

46008

Valencia

46011

Valencia

46013

Valencia

46021

Valencia

46022

Valencia

46023

Valencia

46024

Valencia

46110

Burjassot

46183

L'Eliana

46200

Valencia

46930

Quart de Poblet

48013

Bilbao

04007

Almería

04009

Almería

04120

Almería

08310

Argentona

08017

Barcelona

08025

Barcelona

08208

Sabadell

08930

Sant Adrià de Besòs

08195

Sant Cugat del Vallès

08197

Sant Cugat del Vallès

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY